CClinicalTrials.gg
CompletedNCT05889039Updated Nov 15, 2023Results posted

Effects of Osteopathic Manipulative Treatment and Bio Electro-Magnetic Regulation Therapy on Neck Pain in Adults

An interventional study of BEMER and OMT in Neck Pain, sponsored by Lake Erie College of Osteopathic Medicine. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2023-11-15.

Sponsored by Lake Erie College of Osteopathic Medicine · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 7 months after the study started (first participant enrolled Sep 2019, registered May 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Sex
All
01

Study summary

Neck pain is a common ailment in the United States. Although there are several different treatments and approaches to help individuals with neck pain, the number affected by this condition has been steadily increasing.

OMT has been shown to be helpful in the treatment of neck pain. In fact, the use of OMT has been shown to increase mobility of the myofascial tissues, visceral motion and decrease pain in patients with neck pain. Bio Electro-Magnetic Regulation (BEMER) Therapy is a therapeutic modality that deploys a biorhythmically defined stimulus through a Pulsed Electromagnetic Field (PEMF), which leads to an increase in blood flow. The positive effects of BEMER on the circulation has been shown to result in significant increases in arteriovenous oxygen difference, number of open capillaries, arteriolar and venular flow volume, and flow rate of red blood cells in the microvasculature. Therefore, BEMER can potentially be used in the treatment of neck pain by improving microcirculation in muscular tissue. Therefore, it is possible that the combination of OMT and BEMER therapy may provide additive effects in reducing neck pain. The purpose of this study is to investigate the individual and combined effects of OMT and BEMER therapy on neck pain in adults.

Read the detailed description

Neck Pain is defined as "pain in the neck with or without pain referred to one or both upper limbs that lasts for at least one day". It has been estimated that 66% of the population will suffer from neck pain at some point during their lifetime and has been reported as the fourth leading cause of disability worldwide. There is considerable variation in the reported prevalence rates of neck pain, most likely because of differences in the definition of neck pain and the lack of homogeneity in the studies. Current available studies suggest the one-year estimated incidence of neck pain to range between 10.4% and 21.3%, with a higher incidence noted in computer and office workers. The prevalence of neck pain ranges from 10% to 20%, and the most common cause of neck pain in adults stems from degenerative changes in the cervical spine. Most cases of neck pain tend to run an episodic course over one's lifetime, thus relapses are relatively common.

The differential diagnosis for neck pain is extensive, and a methodical approach is essential to rule out potentially life-threatening conditions. The vast majority of neck pain is not due to organic pathology, and thus, has been termed "non-specific" or "mechanical". Interventions available to manage neck pain include analgesics, physiotherapy, educational modalities, exercise, and manual therapy. While useful in acute, short-term reduction of pain, analgesic therapy such as NSAIDs (nonsteroidal anti-inflammatory drugs) produce significant side effects of gastrointestinal bleeding and cardiovascular events. Use of opioids, while also useful for acute, short-term pain relief, should produce hesitation in prescription due to risk of opioid dependence and hyperalgesia syndromes.

Osteopathic manipulative treatment (OMT) is a fundamental skill set that osteopathic physicians acquire early during their medical training and is widely utilized among practicing osteopathic physicians to treat neck pain and other musculoskeletal complaints. OMT is a unique, hands-on treatment modality used by osteopathic physicians to augment the conventional management of neck pain and has been studied to demonstrate favorable outcomes in the treatment of neck pain.

In addition to conventional treatment modalities, Bio-Electro-Magnetic Energy Regulation (BEMER) therapy (BEMER International AG) has emerged as a proposed therapeutic option. BEMER therapy utilizes a biorhythmically defined stimulus through a pulsed electromagnetic field. BEMER devices operate with unique parameters and are postulated to have a primary effect of improving tissue microcirculation. BEMER therapy leads to an increase in the number of open capillaries, vasomotion of micro vessels, arteriovenous oxygen difference, arteriolar and venular flow volume, and flow rate of red blood cells in a specific microcirculatory area. Multiple studies have demonstrated positive results in musculoskeletal pain management with the utilization of BEMER therapy. One study in particular demonstrated a potential additive, subjective decrease in reported back pain and improved functional ability after treatment with both OMT and BEMER therapy.

The musculoskeletal, lymphatic, and fascial concepts of OMT have long been comprehensively and collectively proposed as the mechanisms by which the therapy provides alleviation of common musculoskeletal ailments. Existing literature suggests benefit from OMT, however, the need for further exploration of manual therapy remains. As previously discussed, BEMER therapy can reduce musculoskeletal pain via enhanced microcirculation. Therefore, it is plausible that the combination of OMT and BEMER therapy may potentially enhance circulation to the vascular beds in myofascial tissue and could substantially reduce neck pain. The objective of this study was to assess the individual and combined effects of OMT and BEMER therapy in patients with non-specific neck pain.

02

Conditions studied

  • Neck Pain

Browse trials for

Keywords

  • Neck Pain
  • Osteopathic Manipulative Treatment (OMT)
  • BEMER
03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 255 are open to participants now.

This study's enrollment of 44 is below the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Lake Erie College of Osteopathic Medicine is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • LECOM-Bradenton faculty, staff and Students currently enrolled in LECOM- Bradenton's osteopathic medical program, pharmacy program, dental program, and master's program who are currently experiencing neck pain for at least two weeks will be approached for recruitment.

Exclusion criteria

Exclusion Criteria:

  • Subjects will be excluded if they have previously participated in the study, are unable to provide informed consent, are currently pregnant, or have a known medical history of any of the following:

    1. Psychiatric conditions
    2. Skin disorders or open wounds precluding skin contact
    3. Fasciitis or fascial tears
    4. Myositis
    5. Neurological symptoms such as numbness, tingling, weakness in upper extremities
    6. Neoplasia
    7. Bone fracture, osteomyelitis, or osteoporosis
    8. Coagulation problem
    9. Deep vein thrombosis
    10. Adrenal diseases/syndromes
    11. Acute upper or lower respiratory infection
    12. Immunosuppressive syndromes
    13. Radiation or chemotherapy within the past 3 years
    14. Lupus
    15. Osteopenia
    16. Congestive heart failure
    17. BMI greater than 30
    18. Any other autoimmune disease not stated above
    19. Medication changes within the last 4 weeks
    20. Asthma exacerbations within the last 4 weeks
    21. Immunosuppressive therapy as a consequence of organ transplantation
    22. Immunosuppressive therapy as a consequence of allogeneic cellular transplantations or bone marrow stem cell transplantation
    23. Other conditions often requiring immunosuppressive therapy
    24. Anticoagulant therapy
    25. Known sensitivity to the carotid sinus reflex
    26. Advanced carotid disease
    27. Down syndrome
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Sham comparator
    OMT + BEMER PLACEBO

    Participants in the CONTROL group received light touch and BEMER sham treatments. Researchers placed their hands lightly on the subject's cervical paraspinal muscles in the supine position and on the upper thoracic paraspinal muscles in the prone position for approximately 5 minutes. This was done to mimic myofascial release techniques; however, no pressure or action was done. In addition, the subject's laid supine on the BEMER mat (as they would do during a BEMER session), but the device was not activated.

    Procedure: Sham OMT + Sham BEMER

  • Active comparator
    Experimental: Bio Electro-Magnetic Regulation (BEMER) Therapy

    Participants receiving BEMER therapy laid supine on the BEMER mat (BEMER International AG). The BEMER was set at intensity 3 for week 1, intensity 4 for week 2, and intensity 5 for week 3. The B.Pad (BEMER International AG) was placed under their cervical region. B.Pad® settings were set at Program 1 (8 minutes long) in week 1 through week 3. These settings were selected based on the manufacturer's recommendations.

    Device: BEMER

  • Active comparator
    OMT (Osteopathic Manipulative Treatment)

    Participants receiving OMT were treated with a standardized sequence to the areas where somatic dysfunctions were found.

    Procedure: OMT

  • Experimental
    OMT+BEMER

    Participants receiving BEMER therapy laid supine on the BEMER mat (BEMER International AG). The BEMER was set at intensity 3 for week 1, intensity 4 for week 2, and intensity 5 for week 3. The B.Pad (BEMER International AG) was placed under their cervical region. B.Pad® settings were set at Program 1 (8 minutes long) in week 1 through week 3. These settings were selected based on the manufacturer's recommendations. OMT was performed prior to BEMER therapy for those in the combined group. Participants were treated with a standardized sequence to the areas where somatic dysfunctions were found.

    Device: BEMER · Procedure: OMT

Interventions

  • DeviceBEMER

    Bio-Electro-Magnetic Energy Regulation (BEMER) is an emerging therapeutic modality that deploys a biorhythmically defined stimulus through a pulsed electromagnetic field and has been shown to reduce musculoskeletal pain.

  • ProcedureOMT

    Osteopathic manipulative therapy (OMT) is a form of manual therapy utilized by osteopathic physicians and some allopathic physicians to treat a broad variety of musculoskeletal ailments, including neck pain.

  • ProcedureSham OMT + Sham BEMER

    Participants in the CONTROL group received light touch and BEMER sham treatments. Researchers placed their hands lightly on the subject's cervical paraspinal muscles in the supine position and on the upper thoracic paraspinal muscles in the prone position for approximately 5 minutes. This was done to mimic myofascial release techniques; however, no pressure or action was done. In addition, the subject's laid supine on the BEMER mat (as they would do during a BEMER session), but the device was not activated.

06

What researchers measure

Primary outcomes

  1. Neck Pain Rating Neck Disability Index (NDI)

    Assessed by questionnaire rating, compared with pre-intervention rating Neck Disability Index (NDI). Score ranges 0-50. Minimum score=0 (no activity limitation), Maximum score=50 (complete activity limitation). Lower scores is better as it reflect lower activity limitation

    Time frame: Within 1 week of completion of 3-week intervention period

  2. Neck Pain Rating Visual Analog Scale (VAS)

    Assessed by questionnaire rating, compared with pre-intervention rating Visual Analog Scale (VAS). Score ranges 0-100. Minimum score=0 (no pain), Maximum score=100 (worst pain ever felt). Lower scores is better as it reflect lower pain

    Time frame: Within 1 week of completion of 3-week intervention period

  3. Quality of Life Rating Short Form 12-item (SF-12) Health Survey

    Assessed by questionnaire rating, compared with pre-intervention rating Short form 12-item (SF-12) health survey. Scores range 0%-100%. Score of 0 (minimum) no pain. Score of 100 (maximum) lot of pain. Lower scores is better as it reflect lower pain

    Time frame: Within 1 week of completion of 3-week intervention period

07

Results

Posted Nov 15, 2023

Participant flow

Participant flow — Overall Study
MilestoneOMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMER
Started12121010
Completed8101010
Not completed4200
Withdrew: Error in completing survey0200
Withdrew: Lost to follow-up4000

Outcome measures

PrimaryNeck Pain Rating Neck Disability Index (NDI)

Assessed by questionnaire rating, compared with pre-intervention rating Neck Disability Index (NDI). Score ranges 0-50. Minimum score=0 (no activity limitation), Maximum score=50 (complete activity limitation). Lower scores is better as it reflect lower activity limitation

Time frame:
Within 1 week of completion of 3-week intervention period
Reported as:
Mean · units on a scale
Neck Pain Rating Neck Disability Index (NDI)
units on a scaleOMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMER
Neck Pain Rating Neck Disability Index (NDI)13 ± 7.67.4 ± 8.512.2 ± 10.911.2 ± 7.6
PrimaryNeck Pain Rating Visual Analog Scale (VAS)

Assessed by questionnaire rating, compared with pre-intervention rating Visual Analog Scale (VAS). Score ranges 0-100. Minimum score=0 (no pain), Maximum score=100 (worst pain ever felt). Lower scores is better as it reflect lower pain

Time frame:
Within 1 week of completion of 3-week intervention period
Reported as:
Mean · units on a scale
Neck Pain Rating Visual Analog Scale (VAS)
units on a scaleOMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMER
Neck Pain Rating Visual Analog Scale (VAS)15.5 ± 13.47.1 ± 10.816 ± 14.211.5 ± 8.4
PrimaryQuality of Life Rating Short Form 12-item (SF-12) Health Survey

Assessed by questionnaire rating, compared with pre-intervention rating Short form 12-item (SF-12) health survey. Scores range 0%-100%. Score of 0 (minimum) no pain. Score of 100 (maximum) lot of pain. Lower scores is better as it reflect lower pain

Time frame:
Within 1 week of completion of 3-week intervention period
Reported as:
Mean · units on a scale
Quality of Life Rating Short Form 12-item (SF-12) Health Survey
units on a scaleOMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMER
Quality of Life Rating Short Form 12-item (SF-12) Health Survey47.5 ± 11.145.4 ± 943.7 ± 14.745.6 ± 13

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
OMT + BEMER PLACEBO0/12 (0%)0/12 (0%)0/12 (0%)
Experimental: Bio Electro-Magnetic Regulation (BEMER) Therapy0/12 (0%)0/12 (0%)0/12 (0%)
OMT (Osteopathic Manipulative Treatment)0/10 (0%)0/10 (0%)0/10 (0%)
OMT+BEMER0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)OMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMERTotal
<=18 years00000
Between 18 and 65 years1212101044
>=65 years00000
Age, Continuous
Age, Continuous(years)OMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMERTotal
Mean25.3 ± 1.624.6 ± 1.625.9 ± 2.524.8 ± 1.825.2 ± 1.8
Sex: Female, Male
Sex: Female, Male(Participants)OMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMERTotal
Female897832
Male433212
Race (NIH/OMB)
Race (NIH/OMB)(Participants)OMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMERTotal
American Indian or Alaska Native00000
Asian00000
Native Hawaiian or Other Pacific Islander00000
Black or African American00000
White00000
More than one race00000
Unknown or Not Reported1212101044
Region of Enrollment
Region of Enrollment(participants)OMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMERTotal
United States1212101044
Visual Analog Scale
Visual Analog Scale(units on a scale)OMT + BEMER PLACEBOExperimental: Bio Electro-Magnetic Regulation (BEMER) TherapyOMT (Osteopathic Manipulative Treatment)OMT+BEMERTotal
Mean20.3 ± 20.213.2 ± 14.016.5 ± 13.832.9 ± 33.420.7 ± 20.4
08

Study locations

1 site
  • Lake Erie College of Osteopathic Medicine
    Bradenton, Florida 34211, United States
09

References and documents

Study documents

  • Protocol, analysis plan and consent form · Nov 18, 2021

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05889039
Lead sponsor
Lake Erie College of Osteopathic Medicine
Responsible party
Santiago Lorenzo, PhD (Professor of Physiology, Lake Erie College of Osteopathic Medicine) — Principal investigator
First posted
Jun 5, 2023
Start date
Sep 17, 2019
Primary completion
Feb 16, 2022
Completion
Feb 16, 2022
Results posted
Nov 15, 2023
Last update
Nov 15, 2023

Study contacts

Santiago Lorenzo, PhD, MS
principal investigator · Lake Erie College of Osteopathic Medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion